Christopher Del Orefice Becton Dickinson & CO (BDX) insider trading activity

Christopher Del Orefice is EVP & Chief Financial Officer of BECTON DICKINSON & CO. Currently has a direct ownership of 22,982 shares of BDX, which is worth approximately $4.39 Million. The most recent transaction as insider was on Nov 26, 2025, when has been sold 4,245 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23K

8.3% 3M change

6.9% 12M change

Total Value Held $4.39 Million

Christopher DelOrefice Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 26 2025	SELL Payment of exercise price or tax liability	-	4,245 Reduced 15.59%	22,982 Common Stock
Nov 26 2025	BUY Grant, award, or other acquisition	-	6,006 Added 18.07%	27,227 Common Stock
Sep 01 2025	SELL Payment of exercise price or tax liability	-	278 Reduced 1.29%	21,221 Common Stock
Nov 26 2024	SELL Payment of exercise price or tax liability	-	5,192 Reduced 19.45%	21,499 Common Stock
Nov 26 2024	BUY Grant, award, or other acquisition	-	13,899 Added 34.24%	26,691 Common Stock
Sep 07 2024	SELL Payment of exercise price or tax liability	-	466 Reduced 3.51%	12,792 Common Stock
Sep 01 2024	SELL Payment of exercise price or tax liability	-	254 Reduced 1.88%	13,258 Common Stock

Nov 26 2023	SELL Payment of exercise price or tax liability	-	812 Reduced 5.67%	13,512 Common Stock
Nov 26 2023	BUY Grant, award, or other acquisition	-	3,325 Added 18.84%	14,324 Common Stock
Sep 07 2023	SELL Payment of exercise price or tax liability	-	601 Reduced 5.18%	10,999 Common Stock
Sep 01 2023	SELL Payment of exercise price or tax liability	-	353 Reduced 2.95%	11,600 Common Stock
Nov 26 2022	SELL Payment of exercise price or tax liability	-	269 Reduced 2.2%	11,953 Common Stock
Nov 26 2022	BUY Grant, award, or other acquisition	-	3,087 Added 20.16%	12,222 Common Stock
Sep 07 2022	SELL Payment of exercise price or tax liability	-	506 Reduced 5.25%	9,135 Common Stock
Sep 01 2022	BUY Grant, award, or other acquisition	-	2,674 Added 21.71%	9,641 Common Stock
Nov 26 2021	BUY Grant, award, or other acquisition	-	2,608 Added 27.24%	6,967 Common Stock
Sep 07 2021	BUY Grant, award, or other acquisition	-	4,359 Added 50.0%	4,359 Common Stock

Also insider at

RSMDF

RESMED INC Healthcare

Director

ULTA

Ulta Beauty, Inc. Consumer Cyclical

Chief Financial Officer